Movano Health (Nasdaq:MOVE) announced today that it received FDA 510(k) clearance for the pulse oximeter in its EvieMED Ring.

Novocure this week announced positive topline results from its Phase 3 trial of its Tumor Treating Fields for pancreatic cancer.

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

Exactech today announced the first surgeries performed with its new Exactech GPS Ankle technology for total ankle replacement ...

Nonin CEO John Hastings said TruO2 OTC offers "equitable, medical-grade technology that is designed for accuracy across all ...

Nervonik announced today that it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device ...

Profound Medical (Nasdaq:PROF) today announced a co-sales and co-marketing agreement for imaging technology with Siemens ...

Boston Scientific (NYSE:BSX) today announced the appointment of Xavier Bertrand as president and SVP for the EMEA region.

GE HealthCare (Nasdaq:GEHC) has unveiled Sonic DL for 3D, a new deep learning innovation for the company's imaging portfolio.